Syndrome de Sjögren: enfin une nouvelle approche de traitement [Sjögren's syndrome: a new approach to treatment].
Data(s) |
2012
|
---|---|
Resumo |
Södgren's syndrome treatment has essentially been based on symptomatic approach and has been of limited efficacy. Novel biological therapies targeting B cells, a key player in the pathophysiology of the syndrome, have recently been tested in controlled clinical trials and raise the hope of improving glandular and extraglandular manifestations of Söigren's syndrome. |
Identificador |
http://serval.unil.ch/?id=serval:BIB_1ED13D02C38D isbn:1660-9379 (Print) pmid:22594008 |
Idioma(s) |
fr |
Fonte |
Revue Médicale Suisse, vol. 8, no. 337, pp. 843-847 |
Palavras-Chave | #Antibodies, Monoclonal, Murine-Derived/therapeutic use; Antirheumatic Agents/therapeutic use; Clinical Trials as Topic; Humans; Muscarinic Agonists/therapeutic use; Sjogren's Syndrome/complications; Sjogren's Syndrome/drug therapy |
Tipo |
info:eu-repo/semantics/article article |